GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cyclo Therapeutics Inc (NAS:CYTH) » Definitions » Cyclically Adjusted PB Ratio

Cyclo Therapeutics (Cyclo Therapeutics) Cyclically Adjusted PB Ratio : 0.44 (As of May. 28, 2024)


View and export this data going back to 2020. Start your Free Trial

What is Cyclo Therapeutics Cyclically Adjusted PB Ratio?

As of today (2024-05-28), Cyclo Therapeutics's current share price is $1.35. Cyclo Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was $3.07. Cyclo Therapeutics's Cyclically Adjusted PB Ratio for today is 0.44.

The historical rank and industry rank for Cyclo Therapeutics's Cyclically Adjusted PB Ratio or its related term are showing as below:

CYTH' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.2   Med: 5.31   Max: 22.29
Current: 0.44

During the past years, Cyclo Therapeutics's highest Cyclically Adjusted PB Ratio was 22.29. The lowest was 0.20. And the median was 5.31.

CYTH's Cyclically Adjusted PB Ratio is ranked better than
88.46% of 693 companies
in the Drug Manufacturers industry
Industry Median: 1.86 vs CYTH: 0.44

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Cyclo Therapeutics's adjusted book value per share data for the three months ended in Mar. 2024 was $0.021. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $3.07 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Cyclo Therapeutics Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Cyclo Therapeutics's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyclo Therapeutics Cyclically Adjusted PB Ratio Chart

Cyclo Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.86 1.11 0.96 0.38 0.50

Cyclo Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.23 0.46 0.43 0.50 0.45

Competitive Comparison of Cyclo Therapeutics's Cyclically Adjusted PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Cyclo Therapeutics's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cyclo Therapeutics's Cyclically Adjusted PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cyclo Therapeutics's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Cyclo Therapeutics's Cyclically Adjusted PB Ratio falls into.



Cyclo Therapeutics Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Cyclo Therapeutics's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.35/3.07
=0.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cyclo Therapeutics's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Cyclo Therapeutics's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.021/131.7762*131.7762
=0.021

Current CPI (Mar. 2024) = 131.7762.

Cyclo Therapeutics Quarterly Data

Book Value per Share CPI Adj_Book
201406 5.992 100.560 7.852
201409 8.493 100.428 11.144
201412 8.030 99.070 10.681
201503 7.342 99.621 9.712
201506 6.681 100.684 8.744
201509 8.183 100.392 10.741
201512 6.385 99.792 8.431
201603 5.182 100.470 6.797
201606 5.773 101.688 7.481
201609 3.522 101.861 4.556
201612 2.279 101.863 2.948
201703 3.371 102.862 4.319
201706 2.235 103.349 2.850
201709 1.425 104.136 1.803
201712 1.570 104.011 1.989
201803 0.456 105.290 0.571
201806 1.150 106.317 1.425
201809 0.248 106.507 0.307
201812 1.094 105.998 1.360
201903 -0.862 107.251 -1.059
201906 4.016 108.070 4.897
201909 2.876 108.329 3.498
201912 0.770 108.420 0.936
202003 -1.397 108.902 -1.690
202006 -1.355 108.767 -1.642
202009 -0.309 109.815 -0.371
202012 2.191 109.897 2.627
202103 2.253 111.754 2.657
202106 1.729 114.631 1.988
202109 1.182 115.734 1.346
202112 1.865 117.630 2.089
202203 1.551 121.301 1.685
202206 1.154 125.017 1.216
202209 0.664 125.227 0.699
202212 0.087 125.222 0.092
202303 -0.042 127.348 -0.043
202306 -0.097 128.729 -0.099
202309 -0.054 129.860 -0.055
202312 0.167 129.419 0.170
202403 0.021 131.776 0.021

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Cyclo Therapeutics  (NAS:CYTH) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Cyclo Therapeutics Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Cyclo Therapeutics's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Cyclo Therapeutics (Cyclo Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
6714 North West 16th Street, Suite B, Gainesville, FL, USA, 32653
Cyclo Therapeutics Inc is a clinical-stage biotechnology firm. The company develops cyclodextrin-based products for the treatment of disease. Its drug candidate, Trappsol Cyclo, treats Niemann-Pick Type C disease (NPC). Its other products include Trappsol HPB, Trappsol Fine Chemical, and Aquaplex.
Executives
Vivien Wong director 6C CHATEAUX CIRCLE, SCARSDALE NY 10583
Rafael Holdings, Inc. 10 percent owner 520 BROAD STREET, NEWARK NJ 07120
William Conkling director C/O RAFAEL HOLDINGS, INC., 520 BROAD ST, NEWARK NJ 07102
Jeffrey Tate director, officer: Chief Executive Officer C/O CTD HOLDINGS, INC., 27317 NW 78TH AVENUE, HIGH SPRINGS FL 32643
Francis Patrick Ostronic director 932 HUNGERFORD DRIVE, SUITE 28A, ROCKVILLE MD 20850
Markus Sieger director BEUTSTWEG 12, CH-8032, ZURICH V8 000000000
N Scott Fine director 600 3RD AVE, NEW YORK NY 10016
Sharon Hemond Hrynkow officer: SVP for Medical Affairs 4816 KING SOLOMON DRIVE, ANNADALE VA 22003
Lise Lund Kjems officer: Chief Medical Officer 91 ROLLINGWOOD LN., CONCORD MA 01742
Joshua M Fine officer: Chief Financial Officer 21 HEMMELSKAMP ROAD, WILTON CT 06897
Armistice Capital Master Fund Ltd. 10 percent owner C/O ARMISTICE CAPITAL, LLC, 510 MADISON AVENUE, 7TH FLOOR, NEW YORK NY 10022
Michael Eric Lisjak officer: Chief Regulatory Officer 12 ROOSEVELT AVENUE, OLD GREENWICH CT 06870
Steven Boyd 10 percent owner 510 MADISON AVENUE, 7TH FLOOR, NEW YORK NY 10022
Armistice Capital, Llc 10 percent owner 510 MADISON AVENUE, 7TH FLOOR, NEW YORK NY 10022
L.p. Novit, 10 percent owner 966 HUNGERFORD DRIVE, ROCKVILLE MD 20850

Cyclo Therapeutics (Cyclo Therapeutics) Headlines

From GuruFocus